Detalles de la búsqueda
1.
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features.
Curr Treat Options Oncol
; 24(11): 1550-1567, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801207
2.
Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis.
Int J Mol Sci
; 24(24)2023 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38139411
3.
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials.
J Pers Med
; 14(5)2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793046
4.
SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer.
Cancers (Basel)
; 15(19)2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835502
5.
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 15(15)2023 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568570
6.
COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis.
EClinicalMedicine
; 66: 102330, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38162948
7.
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy.
Cancers (Basel)
; 15(14)2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509369
8.
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre.
Cancers (Basel)
; 15(17)2023 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686588
Resultados
1 -
8
de 8
1
Próxima >
>>